{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:58:07Z","timestamp":1765486687674,"version":"build-2065373602"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.smim.2021.101513","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T01:48:57Z","timestamp":1637718537000},"page":"101513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Messing with \u03b2c: A unique receptor with many goals"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5844-7644","authenticated-orcid":false,"given":"Winnie L.","family":"Kan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3817-0860","authenticated-orcid":false,"given":"Karen S.","family":"Cheung Tung Shing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3393-1843","authenticated-orcid":false,"given":"Tracy L.","family":"Nero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Hercus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Tvorogov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3101-1138","authenticated-orcid":false,"given":"Michael W.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel F.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.smim.2021.101513_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1101\/cshperspect.a028514","article-title":"Role of the beta common (betac) family of cytokines in health and disease","volume":"10","author":"Hercus","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2013.03.002","article-title":"Signalling by the betac family of cytokines","volume":"24","author":"Hercus","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.smim.2021.101513_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800100-4.00001-5","article-title":"Multifarious determinants of cytokine receptor signaling specificity","volume":"121","author":"Moraga","year":"2014","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.smim.2021.101513_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-032713-120211","article-title":"Insights into cytokine-receptor interactions from cytokine engineering","volume":"33","author":"Spangler","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2021.101513_bib0025","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.3389\/fimmu.2018.02143","article-title":"Mapping determinants of cytokine signaling via protein engineering","volume":"9","author":"Gorby","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2021.101513_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.02.011","article-title":"Decoupling the functional pleiotropy of stem cell factor by tuning c-Kit signaling","volume":"168","author":"Ho","year":"2017","journal-title":"Cell"},{"issue":"6442","key":"10.1016\/j.smim.2021.101513_bib0035","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav7532","article-title":"Topological control of cytokine receptor signaling induces differential effects in hematopoiesis","volume":"364","author":"Mohan","year":"2019","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.smim.2021.101513_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.02.026","article-title":"Functional selectivity in cytokine signaling revealed through a pathogenic EPO mutation","volume":"168","author":"Kim","year":"2017","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.smim.2021.101513_bib0045","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.str.2016.05.017","article-title":"Conformational changes in the GM-CSF receptor suggest a molecular mechanism for affinity conversion and receptor signaling","volume":"24","author":"Broughton","year":"2016","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.smim.2021.101513_bib0050","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41467-017-02633-7","article-title":"A dual role for the N-terminal domain of the IL-3 receptor in cell signalling","volume":"9","author":"Broughton","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.smim.2021.101513_bib0055","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.celrep.2014.06.038","article-title":"Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody","volume":"8","author":"Broughton","year":"2014","journal-title":"Cell Rep."},{"issue":"7746","key":"10.1016\/j.smim.2021.101513_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41586-019-0988-7","article-title":"Structure of the IFNgamma receptor complex guides design of biased agonists","volume":"567","author":"Mendoza","year":"2019","journal-title":"Nature"},{"issue":"7395","key":"10.1016\/j.smim.2021.101513_bib0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10975","article-title":"Exploiting a natural conformational switch to engineer an interleukin-2\u2019 superkine\u2019","volume":"484","author":"Levin","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.smim.2021.101513_bib0070","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.immuni.2015.04.018","article-title":"Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps","volume":"42","author":"Mitra","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0075","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cell.2008.05.053","article-title":"The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation","volume":"134","author":"Hansen","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.smim.2021.101513_bib0080","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/376230a0","article-title":"Crystal structure of a complex between inteferon-gamma and its soluble high-affinity receptor","volume":"376","author":"Walter","year":"1995","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.smim.2021.101513_bib0085","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/pro.5560060821","article-title":"Multiple conformations of a human interleukin-3 variant","volume":"6","author":"Feng","year":"1997","journal-title":"Protein Sci."},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0090","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1006\/jmbi.1996.0337","article-title":"Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3","volume":"259","author":"Feng","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.smim.2021.101513_bib0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/363172a0","article-title":"A novel dimer configuration revealed by the crystal structure at 2.4\u00c5 resolution of human interleukin-5","volume":"363","author":"Milburn","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.smim.2021.101513_bib0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1749-6632.1994.tb39796.x","article-title":"The three-dimensional structure of human interleukin-5 at 2.4-angstroms resolution: implication for the structures of other cytokines","volume":"725","author":"Wells","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.smim.2021.101513_bib0105","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1002\/j.1460-2075.1989.tb08541.x","article-title":"Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor","volume":"8","author":"Gearing","year":"1989","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20091745","article-title":"The Ig-like domain of human GM-CSF receptor alpha plays a critical role in cytokine binding and receptor activation","volume":"426","author":"Mirza","year":"2010","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.smim.2021.101513_bib0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2007.12.030","article-title":"Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4\/13 system","volume":"132","author":"LaPorte","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.str.2010.01.003","article-title":"Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2","volume":"18","author":"Lupardus","year":"2010","journal-title":"Structure"},{"issue":"6","key":"10.1016\/j.smim.2021.101513_bib0125","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/pro.2072","article-title":"Structural basis of interleukin-5 dimer recognition by its alpha receptor","volume":"21","author":"Kusano","year":"2012","journal-title":"Protein Sci."},{"issue":"12","key":"10.1016\/j.smim.2021.101513_bib0130","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.str.2011.08.015","article-title":"Structure analysis of the IL-5 ligand-receptor complex reveals a wrench-like architecture for IL-5Ralpha","volume":"19","author":"Patino","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.smim.2021.101513_bib0135","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1002\/j.1460-2075.1995.tb07345.x","article-title":"Detailed analysis of the IL-5-IL-5R alpha interaction: characterization of crucial residues on the ligand and the receptor","volume":"14","author":"Cornelis","year":"1995","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.smim.2021.101513_bib0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cyto.2007.12.010","article-title":"Slow-dissociation effect of common signaling subunit beta c on IL5 and GM-CSF receptor assembly","volume":"42","author":"Ishino","year":"2008","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.smim.2021.101513_bib0145","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1074\/jbc.M309327200","article-title":"Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognition","volume":"279","author":"Ishino","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2021.101513_bib0150","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/eji.1830250710","article-title":"Characterization of critical residues in the cytoplasmic domain of the human interleukin-5 receptor alpha chain required for growth signal transduction","volume":"25","author":"Cornelis","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2021.101513_bib0155","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1073\/pnas.92.24.10879","article-title":"Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition","volume":"92","author":"Morton","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2021.101513_bib0160","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1073\/pnas.92.11.5194","article-title":"Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist","volume":"92","author":"Tavernier","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2021.101513_bib0165","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0092-8674(91)90039-2","article-title":"Expression Cloning of the Human IL-3 Receptor cDNA Reveals a Shared \u03b2 Subunit for the Human IL-3 and GM-CSF Receptors","volume":"66","author":"Kitamura","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.smim.2021.101513_bib0170","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood.V89.3.842","article-title":"Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function","volume":"89","author":"Barry","year":"1997","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.smim.2021.101513_bib0175","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1074\/jbc.M808197200","article-title":"A new isoform of interleukin-3 receptor {alpha} with novel differentiation activity and high affinity binding mode","volume":"284","author":"Chen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.smim.2021.101513_bib0180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-8674(01)00213-6","article-title":"Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration","volume":"104","author":"Carr","year":"2001","journal-title":"Cell"},{"issue":"Pt 6","key":"10.1016\/j.smim.2021.101513_bib0185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1107\/S1744309106016812","article-title":"An improved resolution structure of the human beta common receptor involved in IL-3, IL-5 and GM-CSF signalling which gives better definition of the high-affinity binding epitope","volume":"62","author":"Carr","year":"2006","journal-title":"Acta Crystallogr. Section F, Struct. Biol. Crystall. Commun."},{"issue":"1","key":"10.1016\/j.smim.2021.101513_bib0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-065X.2012.01164.x","article-title":"The GM-CSF\/IL-3\/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling","volume":"250","author":"Broughton","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2021.101513_bib0195","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.91.1.252","article-title":"Histidine-367 of the human common beta chain of the receptor is critical for high-affinity binding of human granulocyte-macrophage colony-stimulating factor","volume":"91","author":"Lock","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"25","key":"10.1016\/j.smim.2021.101513_bib0200","doi-asserted-by":"crossref","first-page":"26500","DOI":"10.1074\/jbc.M402705200","article-title":"Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains","volume":"279","author":"Murphy","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.smim.2021.101513_bib0205","doi-asserted-by":"crossref","first-page":"10572","DOI":"10.1074\/jbc.M211664200","article-title":"A novel functional epitope formed by domains 1 and 4 of the human common beta-subunit is involved in receptor activation by granulocyte macrophage colony-stimulating factor and interleukin 5","volume":"278","author":"Murphy","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2021.101513_bib0210","doi-asserted-by":"crossref","first-page":"25999","DOI":"10.1074\/jbc.271.42.25999","article-title":"A single tyrosine residue in the membrane-proximal domain of the GM-CSF, IL-3 and IL-5 receptor common \u03b2 chain is necessary and sufficient for high affinity binding and signalling by all three ligands","volume":"271","author":"Woodcock","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.smim.2021.101513_bib0215","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1002\/j.1460-2075.1994.tb06848.x","article-title":"Three residues in the common beta chain of the human GM-CSF, IL-3 and IL-5 receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF","volume":"13","author":"Woodcock","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.smim.2021.101513_bib0220","doi-asserted-by":"crossref","first-page":"31922","DOI":"10.1074\/jbc.271.50.31922","article-title":"A discontinuous eight-amino acid epitope in human interleukin-3 binds the \u03b1-chain of its receptor","volume":"271","author":"Bagley","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2021.101513_bib0225","doi-asserted-by":"crossref","first-page":"8488","DOI":"10.1016\/S0021-9258(17)37220-4","article-title":"Two contiguous residues in human interleukin-3, Asp21 and Glu22, selectively interact with the \u03b1- and \u03b2-chains of its receptor and participate in function","volume":"269","author":"Barry","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2021.101513_bib0230","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1073\/pnas.91.13.5838","article-title":"Specific human granulocyte-macrophage colony-stimulating factor antagonists","volume":"91","author":"Hercus","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.smim.2021.101513_bib0235","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood-2008-12-164004","article-title":"The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease","volume":"114","author":"Hercus","year":"2009","journal-title":"Blood"},{"issue":"36","key":"10.1016\/j.smim.2021.101513_bib0240","doi-asserted-by":"crossref","first-page":"22630","DOI":"10.1074\/jbc.272.36.22630","article-title":"The receptor binding site of human interleukin-3 defined by mutagenesis and molecular modeling","volume":"272","author":"Klein","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.smim.2021.101513_bib0245","doi-asserted-by":"crossref","first-page":"22370","DOI":"10.1074\/jbc.M110.117465","article-title":"Two modes of beta-receptor recognition are mediated by distinct epitopes on mouse and human interleukin-3","volume":"285","author":"Mirza","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2021.101513_bib0250","doi-asserted-by":"crossref","first-page":"23754","DOI":"10.1074\/jbc.270.40.23754","article-title":"Saturation mutagenesis of human Interleukin-3","volume":"270","author":"Olins","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.smim.2021.101513_bib0255","doi-asserted-by":"crossref","first-page":"e5188","DOI":"10.1371\/journal.pone.0005188","article-title":"A cytokine-cytokine interaction in the assembly of higher-order structure and activation of the interleukine-3:receptor complex","volume":"4","author":"Dey","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2021.101513_bib0260","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/S0021-9258(18)53290-7","article-title":"Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5","volume":"268","author":"Devos","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2021.101513_bib0265","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1073\/pnas.88.24.11349","article-title":"Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family","volume":"88","author":"Murakami","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2021.101513_bib0270","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1074\/jbc.271.7.3562","article-title":"Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly actviates p93fes, STAT1 p91, and STAT3 p92 in Polymorphonuclear Leukocytes","volume":"271","author":"Brizzi","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2021.101513_bib0275","first-page":"4335","article-title":"JAK2 associates with the \u03b2c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane proximal region","volume":"14","author":"Quelle","year":"1994","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.smim.2021.101513_bib0280","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1182\/blood.V91.9.3182","article-title":"Interleukin-3-induced activation of the JAK\/STAT pathway is prolonged by proteasome inhibitors","volume":"91","author":"Callus","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0285","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","article-title":"Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.smim.2021.101513_bib0290","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jcb.20513","article-title":"Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba\/F3 pro-B cells","volume":"96","author":"Huang","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.smim.2021.101513_bib0295","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1182\/blood.V91.7.2264","article-title":"JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor \u03b1 and \u03b2c subunit, respectively, and are activated upon IL-5 stimulation","volume":"91","author":"Ogata","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.smim.2021.101513_bib0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2017.08.011","article-title":"Jak1 integrates cytokine sensing to regulate hematopoietic stem cell function and stress hematopoiesis","volume":"21","author":"Kleppe","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.smim.2021.101513_bib0305","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.256.5064.1677","article-title":"Rational design of potent antagonsts to the human growth hormone receptor","volume":"256","author":"Fuh","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.smim.2021.101513_bib0310","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1074\/jbc.273.9.5307","article-title":"Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies","volume":"273","author":"Rowlinson","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"6185","key":"10.1016\/j.smim.2021.101513_bib0315","doi-asserted-by":"crossref","DOI":"10.1126\/science.1249783","article-title":"Mechanism of activation of protein kinase JAK2 by the growth hormone receptor","volume":"344","author":"Brooks","year":"2014","journal-title":"Science"},{"issue":"6478","key":"10.1016\/j.smim.2021.101513_bib0320","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.aaw3242","article-title":"Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations","volume":"367","author":"Wilmes","year":"2020","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.smim.2021.101513_bib0325","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/bloodadvances.2016002931","article-title":"High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression","volume":"1","author":"Wittwer","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.smim.2021.101513_bib0330","first-page":"7404","article-title":"A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction","volume":"14","author":"Takaki","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.smim.2021.101513_bib0335","doi-asserted-by":"crossref","first-page":"28287","DOI":"10.1074\/jbc.271.45.28287","article-title":"A dominant negative granulocyte-macrophage colony-stimuating factor receptor alpha chain reveals the multimeric structure of the receptor complex","volume":"271","author":"Lia","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.smim.2021.101513_bib0340","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V97.6.1662","article-title":"Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit mediate activation of Jak\/Stat signaling and differentiation","volume":"97","author":"Lilly","year":"2001","journal-title":"Blood"},{"issue":"6 Pt 2","key":"10.1016\/j.smim.2021.101513_bib0345","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0091-6749(95)70195-8","article-title":"Roles of the cytoplasmic domains of the alpha and beta subunits of human granulocyte-macrophage colony-stimulating factor receptor","volume":"96","author":"Muto","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"issue":"20","key":"10.1016\/j.smim.2021.101513_bib0350","doi-asserted-by":"crossref","first-page":"14607","DOI":"10.1016\/S0021-9258(17)36667-X","article-title":"Mapping the intracytoplasmic regions of the alpha granulocyte- macrophage colony-stimulating factor receptor necessary for cell growth regulation","volume":"269","author":"Polotskaya","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.smim.2021.101513_bib0355","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1182\/blood-2009-08-235846","article-title":"Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit","volume":"115","author":"Perugini","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.smim.2021.101513_bib0360","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1002\/j.1460-2075.1992.tb05437.x","article-title":"Critical cytoplasmic subunit domains of the common \u03b2 subunit of the human GM-CSF,IL-3 and Il-5 receptors for growth signal transduction and tyrosine phosphorylation","volume":"11","author":"Sakamaki","year":"1992","journal-title":"EMBO"},{"issue":"9","key":"10.1016\/j.smim.2021.101513_bib0365","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2001-12-0235","article-title":"Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors","volume":"100","author":"Evans","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0370","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2003-06-1999","article-title":"The phosphoserine-585-dependent pathway of the GM-CSF\/IL-3\/IL-5 receptors mediates hematopoietic cell survival through activation of NF-kappaB and induction of bcl-2","volume":"103","author":"Guthridge","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0375","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.emboj.7600948","article-title":"Growth factor pleiotropy is controlled by a receptor Tyr\/Ser motif that acts as a binary switch","volume":"25","author":"Guthridge","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.smim.2021.101513_bib0380","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1097-2765(05)00002-X","article-title":"Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival","volume":"6","author":"Guthridge","year":"2000","journal-title":"Mol.Cell"},{"issue":"4","key":"10.1016\/j.smim.2021.101513_bib0385","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.immuni.2019.03.022","article-title":"GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation","volume":"50","author":"Dougan","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.smim.2021.101513_bib0390","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrd.2016.231","article-title":"Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases","volume":"16","author":"Hamilton","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.smim.2021.101513_bib0395","first-page":"37","article-title":"Targeting GM-CSF in inflammatory diseases, Nature reviews","volume":"12","author":"Wicks","year":"2016","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.smim.2021.101513_bib0400","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190945","article-title":"GM-CSF in inflammation","volume":"217","author":"Hamilton","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2021.101513_bib0405","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/ITT.S262566","article-title":"GM-CSF: A Promising Target in Inflammation and Autoimmunity","volume":"9","author":"Lee","year":"2020","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.smim.2021.101513_bib0410","article-title":"Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: the role of GM-CSF","author":"Calabrese","year":"2020","journal-title":"Cleve. Clin. J. Med."},{"issue":"8","key":"10.1016\/j.smim.2021.101513_bib0415","first-page":"507","article-title":"GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches, Nature reviews","volume":"20","author":"Lang","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.smim.2021.101513_bib0420","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3389\/fimmu.2020.01625","article-title":"Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies","volume":"11","author":"Bonaventura","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2021.101513_bib0425","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/S2665-9913(20)30170-3","article-title":"GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study","volume":"2","author":"De Luca","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"11","key":"10.1016\/j.smim.2021.101513_bib0430","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.mayocp.2020.08.038","article-title":"GM-CSF neutralization with lenzilumab in severe COVID-19 pneumonia: a case-cohort study","volume":"95","author":"Temesgen","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"10223","key":"10.1016\/j.smim.2021.101513_bib0435","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"10239","key":"10.1016\/j.smim.2021.101513_bib0440","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.smim.2021.101513_bib0445","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20151853","article-title":"GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease","volume":"213","author":"Stock","year":"2016","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0450","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/19420862.2015.1119352","article-title":"CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common beta chain of the IL-3, GM-CSF and IL-5 receptors","volume":"8","author":"Panousis","year":"2016","journal-title":"mAbs"},{"issue":"6","key":"10.1016\/j.smim.2021.101513_bib0455","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1016\/S2665-9913(21)00070-9","article-title":"Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial","volume":"3","author":"Cremer","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.smim.2021.101513_bib0460","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12931-017-0708-5","article-title":"GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte\/macrophage polarization","volume":"19","author":"Halstead","year":"2018","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.smim.2021.101513_bib0465","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40348-016-0055-5","article-title":"Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia-a new therapeutic strategy?","volume":"3","author":"Rosler","year":"2016","journal-title":"Mol. Cell. Pediatr."},{"issue":"4","key":"10.1016\/j.smim.2021.101513_bib0470","doi-asserted-by":"crossref","first-page":"L571","DOI":"10.1152\/ajplung.00296.2019","article-title":"Lower respiratory tract delivery, airway clearance, and preclinical efficacy of inhaled GM-CSF in a postinfluenza pneumococcal pneumonia model","volume":"318","author":"Umstead","year":"2020","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"6","key":"10.1016\/j.smim.2021.101513_bib0475","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86131","article-title":"A cytotoxic anti-IL-3Ralpha antibody targets key cells and cytokines implicated in systemic lupus erythematosus","volume":"1","author":"Oon","year":"2016","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.smim.2021.101513_bib0480","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ki.2015.196","article-title":"IL-3 contributes to development of lupus nephritis in MRL\/lpr mice","volume":"88","author":"Renner","year":"2015","journal-title":"Kidney Int."},{"issue":"6227","key":"10.1016\/j.smim.2021.101513_bib0485","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.aaa4268","article-title":"Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis","volume":"347","author":"Weber","year":"2015","journal-title":"Science"},{"issue":"7869","key":"10.1016\/j.smim.2021.101513_bib0490","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/d41586-021-01870-7","article-title":"A protective signal between the brain\u2019s supporting cells in Alzheimer\u2019s disease","volume":"595","author":"Barron","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.smim.2021.101513_bib0495","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","article-title":"Astrocytic interleukin-3 programs microglia and limits Alzheimer\u2019s disease","volume":"595","author":"McAlpine","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.smim.2021.101513_bib0500","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2009.04.018","article-title":"Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells","volume":"5","author":"Jin","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.smim.2021.101513_bib0505","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","article-title":"The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.smim.2021.101513_bib0510","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood-2002-03-0852","article-title":"Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis","volume":"100","author":"Testa","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.smim.2021.101513_bib0515","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2011.047894","article-title":"High levels of CD34+CD38low\/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study","volume":"96","author":"Vergez","year":"2011","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.smim.2021.101513_bib0520","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/leu.2014.128","article-title":"Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC","volume":"28","author":"Busfield","year":"2014","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.smim.2021.101513_bib0525","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3324\/haematol.2014.113092","article-title":"Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice","volume":"100","author":"Lee","year":"2015","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.smim.2021.101513_bib0530","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood-2012-12-475194","article-title":"Monoclonal antibody targeting of IL-3 receptor alpha with CSL362 effectively depletes CML progenitor and stem cells","volume":"123","author":"Nievergall","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.smim.2021.101513_bib0535","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/leu.2015.16","article-title":"Aberrant expression of CD123 (interleukin-3 receptor-alpha) on neoplastic mast cells","volume":"29","author":"Pardanani","year":"2015","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.smim.2021.101513_bib0540","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3324\/haematol.2014.111740","article-title":"In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent","volume":"100","author":"Angelot-Delettre","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0545","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood-2014-04-566737","article-title":"Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients","volume":"124","author":"Frankel","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0550","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/1078-0432.CCR-19-2329","article-title":"FDA approval summary: tagraxofusp-erzs for treatment of blastic plasmacytoid dendritic cell neoplasm","volume":"26","author":"Jen","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.smim.2021.101513_bib0555","doi-asserted-by":"crossref","first-page":"e40267","DOI":"10.1371\/journal.pone.0040267","article-title":"Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.smim.2021.101513_bib0560","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1331195","article-title":"Targeting IL-5Ralpha with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer","volume":"6","author":"Paquette","year":"2017","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.smim.2021.101513_bib0565","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.cellsig.2013.06.004","article-title":"Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1\/2-mediated MMP-9\/NF-kappaB\/AP-1 pathway: involvement of the p21WAF1 expression","volume":"25","author":"Lee","year":"2013","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.smim.2021.101513_bib0570","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1183\/09031936.00090610","article-title":"Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations","volume":"37","author":"Suzuki","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.smim.2021.101513_bib0575","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1084\/jem.20080990","article-title":"Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA","volume":"205","author":"Suzuki","year":"2008","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0580","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/jmg.2010.082586","article-title":"Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB","volume":"48","author":"Tanaka","year":"2011","journal-title":"J. Med. Genet."},{"issue":"7","key":"10.1016\/j.smim.2021.101513_bib0585","first-page":"1018","article-title":"The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities","volume":"10","author":"Dhagat","year":"2018","journal-title":"mAbs"},{"issue":"7","key":"10.1016\/j.smim.2021.101513_bib0590","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1164\/rccm.200708-1271OC","article-title":"Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan","volume":"177","author":"Inoue","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"19","key":"10.1016\/j.smim.2021.101513_bib0595","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1073\/pnas.1216011110","article-title":"Characterization of pathogenic human monoclonal autoantibodies against GM-CSF","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.smim.2021.101513_bib0600","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.12.046","article-title":"Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn\u2019s disease","volume":"136","author":"Han","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.smim.2021.101513_bib0605","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.06.045","article-title":"A frameshift in CSF2RB predominant among Ashkenazi Jews increases risk for Crohn\u2019s disease and reduces monocyte signaling via GM-CSF","volume":"151","author":"Chuang","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.smim.2021.101513_bib0610","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1053\/j.gastro.2016.06.040","article-title":"Genetic complexity of Crohn\u2019s disease in two large Ashkenazi Jewish families","volume":"151","author":"Levine","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2021.101513_bib0615","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1182\/blood.V83.10.2802.2802","article-title":"A mutation of the common receptor subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor, and IL-5 that leads to ligand independence and tumorigenicity","volume":"83","author":"D\u2019Andrea","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.smim.2021.101513_bib0620","doi-asserted-by":"crossref","first-page":"29707","DOI":"10.1074\/jbc.271.47.29707","article-title":"Interacting residues in the extracellular region of the common \u03b2 subunit of the human GM-CSF, IL-3 and IL-5 receptors involved in constitutive activation","volume":"271","author":"Jenkins","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2021.101513_bib0625","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1002\/j.1460-2075.1995.tb00102.x","article-title":"Activating point mutations in the common \u03b2 subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of \u03b2 subunit dimerization and cell type-specific molecules in signalling","volume":"14","author":"Jenkins","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.smim.2021.101513_bib0630","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1074\/jbc.274.13.8669","article-title":"A Cell Type-specific Constitutive Point Mutant of the Common \u03b2-Subunit of the Human Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF), Interleukin (IL)-3, and IL-5 Receptors Requires the GM-CSF Receptor \u03b1-Subunit for Activation","volume":"274","author":"Jenkins","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.smim.2021.101513_bib0635","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/leu.2016.95","article-title":"Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia","volume":"30","author":"Watanabe-Smith","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.smim.2021.101513_bib0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.06.007","article-title":"Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with down syndrome","volume":"36","author":"Labuhn","year":"2019","journal-title":"Cancer Cell"},{"issue":"41","key":"10.1016\/j.smim.2021.101513_bib0645","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0406491101","article-title":"Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor","volume":"101","author":"Brines","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2021.101513_bib0650","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2015.02.005","article-title":"Flipping the molecular switch for innate protection and repair of tissues: long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin","volume":"151","author":"Collino","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"31","key":"10.1016\/j.smim.2021.101513_bib0655","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.0805594105","article-title":"Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin","volume":"105","author":"Brines","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.smim.2021.101513_bib0660","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072225","article-title":"A phase 2 clinical trial on the use of cibinetide for the treatment of diabetic macular edema","volume":"9","author":"Lois","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.smim.2021.101513_bib0665","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.isci.2019.06.027","article-title":"Transmembrane protein aptamer induces cooperative signaling by the EPO receptor and the cytokine receptor beta-common subunit","volume":"17","author":"He","year":"2019","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.smim.2021.101513_bib0670","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1038\/s41598-018-29865-x","article-title":"EPO does not promote interaction between the erythropoietin and beta-common receptors","volume":"8","author":"Cheung Tung Shing","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.smim.2021.101513_bib0675","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.cell.2015.02.011","article-title":"Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands","volume":"160","author":"Moraga","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.smim.2021.101513_bib0680","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.1998.tb09554.x","article-title":"Interleukin-3 and interleukin-3 receptors in the brain","volume":"840","author":"Tabira","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0685","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/08977190109001082","article-title":"Interleukin-5 receptor alpha chain expression and splicing during brain development in mice","volume":"19","author":"Lins","year":"2001","journal-title":"Growth Factors"},{"key":"10.1016\/j.smim.2021.101513_bib0690","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2202-8-82","article-title":"Interleukin-3 prevents neuronal death induced by amyloid peptide","volume":"8","author":"Zambrano","year":"2007","journal-title":"BMC Neurosci."},{"issue":"11","key":"10.1016\/j.smim.2021.101513_bib0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050375","article-title":"The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"},{"issue":"7738","key":"10.1016\/j.smim.2021.101513_bib0700","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41586-018-0830-7","article-title":"De novo design of potent and selective mimics of IL-2 and IL-15","volume":"565","author":"Silva","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.smim.2021.101513_bib0705","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D","article-title":"Refined crystal structure and mutagenesis of human granulocyte-macrophage colony-stimulating factor","volume":"26","author":"Rozwarski","year":"1996","journal-title":"Proteins"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532321000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532321000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:23:19Z","timestamp":1760916199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532321000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":141,"alternative-id":["S1044532321000440"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2021.101513","relation":{},"ISSN":["1044-5323"],"issn-type":[{"type":"print","value":"1044-5323"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Messing with \u03b2c: A unique receptor with many goals","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2021.101513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101513"}}